- Disclosures must never include the use of a trade name or a product-group message and must be listed once at the bottom of the poster.
- Make the title dynamic and conclusive, rather than descriptive.
- Avoid beginning sentences with numerals.
- Standard abbreviations may be used without definition. Nonstandard abbreviations should be placed in parentheses after the first use of the word or phrase abbreviated.
- No identifying information about patients participating in a study or trial should be used.
- All abbreviations must be defined before being used as an abbreviation in the text.
- Proofread eposter abstracts carefully to avoid errors before submission.
- No corrections will be allowed or made once the poster abstract has been submitted.
- QR codes are permitted.
- All submitted abstracts must be in English
- The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. During submission, it must clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with the submitted abstract.
- All submitted abstracts need to have the names and surnames of all co-authors, along with their positions in their affiliated institutions.
- The presenting author can be any of the listed authors without affiliations to industry.
- Poster submissions need to be limited to 500 words.
- An abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.
- A well-written abstract typically has the following identified sections:
- Background/objectives: a brief introduction, which states the problem that you are addressing as well as some background information on the issue. The introduction of the abstract should include a very brief background 1-2 statements followed by the objectives of the investigation.
- Design and methods: the methodologies, number of test subjects and scientific approach used to conduct the research.
- Results: it is expected that authors present data that support their conclusion. Tables and graphs should include explanatory captions.
- Conclusions: further areas of research and overall conclusion of the research
- Citation: a reference list and acknowledgements, if applicable. A maximum of two tables/graphs/images can be included.
The submitting author must verify that all co-authors have read and approved the submission of the abstract.
Virtual delegates can also submit their abstracts regardless if they are physically present or not. The MENACTRIMS 2021 Congress will provide an ePosters section on their LIVE website available from December 5, 2021.
ePosters are not online poster presentations. Accepted ePosters will be placed on the congress website, each ePoster will have a dedicated page. The main author’s contact will be placed on the ePoster page in the case virtual delegates would like to contact them. Moreover, ePosters pages will contain the submitted abstract along with the design ePoster that accepted abstract authors will need to submit using the MENACTRIMS 2021 abstract template.
Please download the template featured below.
*Please note that ePosters submitted using the below format only will be displayed on the website.
The reviewers will judge the abstracts according to the scientiﬁc or clinical value, relevance to the conference, suitability of methods to aims, conclusions conﬁrmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
Upon completion of the evaluation of submitted abstracts, an ‘Accepted’ or ‘Rejected’ email will be sent to authors. Upon acceptance of an author’s submission, the following instructions below are applicable:.
- Accepted authors will receive one complimentary registration pass that will be assigned and sent up to 10 days prior to the congress
- Authors who confirm presence will receive a free communication code based on their category of submission up to 10 days before the congress.
- If you need to withdraw your abstract, a written statement listing the reasons for this decision must be sent to the abstract helpdesk at email@example.com no later than November 5, 2021
- Virtual authors: are to submit the electronic version of the abstract in PDF format at least 10 days prior to the congress.
- Failure to provide the ePoster on time will not expose the abstract on the LIVE congress website
A disclosure form identifying commercial relationships for all co-authors must be completed by the submitting author, if their abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted abstracts will be made available to the meeting attendees.